Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
- Conditions
- Peripheral T-cell Lymphoma
- Registration Number
- NCT01110733
- Lead Sponsor
- Acrotech Biopharma Inc.
- Brief Summary
Prospective, longitudinal, multinational, observational study that will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in academic and community practices.
- Detailed Description
The COMPLETE registry is a prospective, longitudinal, multinational, observational study that will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in academic and community practices. The registry will enroll newly-diagnosed patients with PTCL treated with a variety of regimens. The COMPLETE registry is designed to better understand PTCL patient characteristics, treatments, and outcomes to help design and understand future clinical trials.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 3000
-
Patient is newly diagnosed with Peripheral T-cell Lymphoma (PTCL):
- Aggressive natural killer (NK)-cell leukemia
- Adult T-cell lymphoma/leukemia (human T-cell leukemia virus [HTLV] 1+)
- Angioimmunoblastic T-cell lymphoma
- Anaplastic large cell lymphoma (ALCL), primary systemic type (ALK+, ALK-)
- PTCL, not otherwise specified (NOS)
- T/NK-cell lymphoma, nasal type
- Enteropathy-type intestinal lymphoma
- Hepatosplenic T-cell lymphoma
- Subcutaneous panniculitis T-cell lymphoma
- Transformed mycosis fungoides (at diagnosis of transformation)
- T-cell prolymphocytic leukemia (T-PLL)
- Cutaneous gamma/delta (ฮณ/ฮด) T-cell lymphoma
- Cutaneous aggressive CD8+ T-cell lymphoma
- Hematodermic neoplasms (blastic plasmacytoid dendritic cell neoplasm)
- Systemic Epstein Barr Virus (EBV)+ T-cell lymphomas (T-cell lymphoproliferative disorders of childhood)
- Other T-Cell lymphomas that are not listed in the Exclusion Criteria
-
Patient gives written informed consent
-
Patient has other T- or NK-cell malignancies including:
- Precursor T/NK neoplasms
- T-cell large granular lymphocytic leukemia
- Mycosis fungoides, other than transformed mycosis fungoides
- Sรฉzary syndrome
- Primary cutaneous CD30+ disorders: ALCL and lymphomatoid papulosis
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (68)
City of Hope National Medical Center
๐บ๐ธDuarte, California, United States
Georgetown University
๐บ๐ธWashington, District of Columbia, United States
Rush University Medical Center
๐บ๐ธChicago, Illinois, United States
University of Chicago Medical Center
๐บ๐ธChicago, Illinois, United States
UIC Cancer Center
๐บ๐ธChicago, Illinois, United States
Boston Medical Center
๐บ๐ธBoston, Massachusetts, United States
University of Miami
๐บ๐ธMiami, Florida, United States
Indiana University Simon Cancer Center
๐บ๐ธIndianapolis, Indiana, United States
St. Francis Medical Group Oncology and Hematology Associates
๐บ๐ธIndianapolis, Indiana, United States
South Texas Oncology and Hematology, P.A.
๐บ๐ธSan Antonio, Texas, United States
Genesis Cancer Center
๐บ๐ธHot Springs, Arkansas, United States
University of Arkansas for Medical Sciences
๐บ๐ธLittle Rock, Arkansas, United States
Arizona Cancer Center
๐บ๐ธTucson, Arizona, United States
UCLA
๐บ๐ธLos Angeles, California, United States
Wilshire Oncology Medical Group
๐บ๐ธLa Verne, California, United States
USC & Norris Cancer Center
๐บ๐ธLos Angeles, California, United States
Moores Cancer Center UCSD
๐บ๐ธLa Jolla, California, United States
UCLA Olive View Medical Center
๐บ๐ธSylmar, California, United States
Danbury Hospital Praxair Cancer Center
๐บ๐ธDanbury, Connecticut, United States
Washington Cancer Institute at Washington Hospital Center
๐บ๐ธWashington, District of Columbia, United States
Hematology Oncology Associates
๐บ๐ธLoxahatchee Groves, Florida, United States
Medical Specialists of the Palm Beaches
๐บ๐ธLake Worth, Florida, United States
Coral Springs Oncology
๐บ๐ธCoral Springs, Florida, United States
Emory University Cancer Center
๐บ๐ธAtlanta, Georgia, United States
Medical College of Georgia
๐บ๐ธAugusta, Georgia, United States
Georgia Cancer Specialists
๐บ๐ธAtlanta, Georgia, United States
ProMedica
๐บ๐ธLambertville, Michigan, United States
Washington University School of Medicine
๐บ๐ธSaint Louis, Missouri, United States
Cancer Institute of New Jersey
๐บ๐ธNew Brunswick, New Jersey, United States
John Theurer Cancer Center at Hackensack University Medical Center
๐บ๐ธHackensack, New Jersey, United States
Overlook Hospital and Morristown Memorial Hospital
๐บ๐ธSummit, New Jersey, United States
Roswell Park Cancer Institute
๐บ๐ธBuffalo, New York, United States
Memorial Sloan-Kettering Cancer Center
๐บ๐ธNew York, New York, United States
New York University Clinical Cancer Center
๐บ๐ธNew York, New York, United States
University of Rochester
๐บ๐ธRochester, New York, United States
Carolina Cancer Management, Inc.
๐บ๐ธFayetteville, North Carolina, United States
Carolinas Medical Center Northeast
๐บ๐ธConcord, North Carolina, United States
Community Cancer Center
๐บ๐ธLorain, Ohio, United States
Fox Chase Cancer Center
๐บ๐ธPhiladelphia, Pennsylvania, United States
Guthrie Clinic, Ltd
๐บ๐ธSayre, Pennsylvania, United States
UT Southwestern
๐บ๐ธDallas, Texas, United States
Center for Cancer and Blood Disorders
๐บ๐ธFort Worth, Texas, United States
JPS Center for Cancer Care
๐บ๐ธFort Worth, Texas, United States
University of Virginia Health System
๐บ๐ธCharlottesville, Virginia, United States
Tyler Hematology Oncology, PA
๐บ๐ธTyler, Texas, United States
University of Wisconsin Comprehensive Cancer Center
๐บ๐ธMadison, Wisconsin, United States
West Virginia University
๐บ๐ธMorgantown, West Virginia, United States
Vanderbilt University Medical Center
๐บ๐ธNashville, Tennessee, United States
West Michigan Cancer Center
๐บ๐ธKalamazoo, Michigan, United States
Dartmouth-Hitchcock Medical Center
๐บ๐ธLebanon, New Hampshire, United States
St. Louis University Cancer Center
๐บ๐ธSaint Louis, Missouri, United States
Louisiana State University Health Science Center (LSUHSC)
๐บ๐ธShreveport, Louisiana, United States
University of Maryland
๐บ๐ธBaltimore, Maryland, United States
Genesys Hurley Cancer Institute
๐บ๐ธFlint, Michigan, United States
Metro Minnesota Community Clinical Oncology Program
๐บ๐ธSaint Louis Park, Minnesota, United States
Kootenai Cancer Center
๐บ๐ธPost Falls, Idaho, United States
John H. Stroger, Jr. Hospital of Cook County
๐บ๐ธChicago, Illinois, United States
University of Tennessee Cancer Institute
๐บ๐ธMemphis, Tennessee, United States
Michigan State University
๐บ๐ธEast Lansing, Michigan, United States
Simmons Cooper Cancer Institute at SIU School of Medicine
๐บ๐ธSpringfield, Illinois, United States
Moffit Cancer Center
๐บ๐ธTampa, Florida, United States
Northwestern University
๐บ๐ธChicago, Illinois, United States
Stanford University Medical Center
๐บ๐ธStanford, California, United States
MD Anderson Orlando
๐บ๐ธOrlando, Florida, United States
Research Medical Center
๐บ๐ธKansas City, Missouri, United States
Yale University School of Medicine
๐บ๐ธNew Haven, Connecticut, United States
University of North Carolina Chapel Hill
๐บ๐ธChapel Hill, North Carolina, United States
DCH Cancer Treatment Center
๐บ๐ธTuscaloosa, Alabama, United States